Market capitalization | €1.14b |
Enterprise Value | €1.11b |
P/E (TTM) P/E ratio | 10.91 |
EV/FCF (TTM) EV/FCF | 8.61 |
EV/Sales (TTM) EV/Sales | 0.33 |
P/S ratio (TTM) P/S ratio | 0.34 |
P/B ratio (TTM) P/B ratio | 0.82 |
Dividend yield | 3.03% |
Last dividend (FY24) | €2.03 |
As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.
6 Analysts have issued a Drägerwerk forecast:
6 Analysts have issued a Drägerwerk forecast:
Mar '25 |
+/-
%
|
||
Revenue | 3,365 3,365 |
1%
1%
|
|
Gross Profit | 1,513 1,513 |
4%
4%
|
|
EBITDA | 341 341 |
8%
8%
|
EBIT (Operating Income) EBIT | 194 194 |
16%
16%
|
Net Profit | 115 115 |
15%
15%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe; Americas; and Africa, Asia, and Austria (AAA). The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.
Head office | Germany |
CEO | Stefan Dräger |
Employees | 16,015 |
Founded | 1889 |
Website | www.draeger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.